Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1993 Feb 15;148(4):638–642.

When science and passion meet: the impact of AIDS on research.

J Pripstein 1
PMCID: PMC1490519  PMID: 8431829

Full text

PDF
638

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger J. W. AIDS, death, and the drug approval process. Am Pharm. 1991 Oct;NS31(10):45–47. doi: 10.1016/s0160-3450(15)31327-1. [DOI] [PubMed] [Google Scholar]
  2. Cotton P. Scientifically astute activists seek common ground with clinicians on testing new AIDS drugs. JAMA. 1990 Aug 8;264(6):666, 669-70, 673. doi: 10.1001/jama.264.6.666. [DOI] [PubMed] [Google Scholar]
  3. Iglehart J. K. The Food and Drug Administration and its problems. N Engl J Med. 1991 Jul 18;325(3):217–220. doi: 10.1056/NEJM199107183250322. [DOI] [PubMed] [Google Scholar]
  4. Johnsson J. CEOs: politics hurts long-term medical research. Hospitals. 1990 Aug 20;64(16):22–22. [PubMed] [Google Scholar]
  5. Kessler D. A. Drug promotion and scientific exchange. The role of the clinical investigator. N Engl J Med. 1991 Jul 18;325(3):201–203. doi: 10.1056/NEJM199107183250310. [DOI] [PubMed] [Google Scholar]
  6. Kessler D. A. FDA's Kessler: a prescription for change. Interview by Marlene Z. Bloom. Am Pharm. 1991 Dec;NS31(12):34–37. [PubMed] [Google Scholar]
  7. Kessler D. A. The regulation of investigational drugs. N Engl J Med. 1989 Feb 2;320(5):281–288. doi: 10.1056/NEJM198902023200504. [DOI] [PubMed] [Google Scholar]
  8. Levine C. Has AIDS changed the ethics of human subjects research? Law Med Health Care. 1988 Fall-Winter;16(3-4):167–173. doi: 10.1111/j.1748-720x.1988.tb01942.x. [DOI] [PubMed] [Google Scholar]
  9. Levine Carol, Dubler Nancy Neveloff, Levine Robert J. Building a new consensus: ethical principles and policies for clinical research on HIV/AIDS. IRB. 1991 Jan-Apr;13(1-2):1–17. [PubMed] [Google Scholar]
  10. Lo B. Clinical ethics and HIV-related illnesses: issues in treatment and health services research. Med Care Rev. 1990 Spring;47(1):15–32. doi: 10.1177/107755879004700103. [DOI] [PubMed] [Google Scholar]
  11. Mariner W. K. New FDA drug approval policies and HIV vaccine development. Am J Public Health. 1990 Mar;80(3):336–341. doi: 10.2105/ajph.80.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McIntosh H. AIDS lobby earns respect from cancer leaders. J Natl Cancer Inst. 1990 May 2;82(9):730–732. doi: 10.1093/jnci/82.9.730. [DOI] [PubMed] [Google Scholar]
  13. Miller Judith N. Ethics review in Canada: highlights from a national workshop, part 2. Ann R Coll Physicians Surg Can. 1990 Jan;23(1):29–33. [PubMed] [Google Scholar]
  14. Rothman D. J., Edgar H. AIDS, activism, and ethics. Hosp Pract (Off Ed) 1991 Jul 15;26(7):135–142. doi: 10.1080/21548331.1991.11704211. [DOI] [PubMed] [Google Scholar]
  15. Spiers H. R. AIDS and civil disobedience. Hastings Cent Rep. 1989 Nov-Dec;19(6):34–35. [PubMed] [Google Scholar]
  16. Wachter R. M. AIDs, activism, and the politics of health. N Engl J Med. 1992 Jan 9;326(2):128–133. doi: 10.1056/NEJM199201093260209. [DOI] [PubMed] [Google Scholar]
  17. Young F. E. The AIDS epidemic and clinical trials. Acad Med. 1989 Nov;64(11):660–661. doi: 10.1097/00001888-198911000-00007. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES